DUBLIN–(BUSINESS WIRE)–The “Global Microtome Market by Product (Instruments, (Rotary), Accessories (Microtome Blades)), Application (Disease Diagnosis, Medical Research), Technology (Fully Automated, Semi-automated, Manual), End-user (Hospital, Clinical Labs), and Region – Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering.
The microtomes market is projected to reach USD 585.2 million by 2027 from USD 425.4 million in 2022, at a CAGR of 6.6%.
Some of the key factors driving the growth of this market include the high prevalence of cancer, growing demand for digital pathology, and the increasing healthcare expenditure. In addition, the growing focus on personalized medicine and the untapped growth potential of emerging economies are expected to offer growth opportunities for players operating in the microtomes market. However, a lack of skilled professionals to operate microtomes is a key challenge for the growth of this market.
Based on end user the market is classified into hospital laboratories, clinical laboratories, and other end-users. The growth of this market is majorly driven by the increasing number of specialty diagnostic tests performed in hospital laboratories, rising number of in-house clinical diagnostic procedures in hospitals, rising number of hospitals across the globe, and the growing trend of establishing in-house clinical diagnostic capabilities in hospitals.
Microtome instruments in the product segment to witness the highest shares during the forecast period
Based on the product, the microtome market is segmented into Microtome Instruments: Rotary Microtomes, Cryostat Microtomes, Vibrating Microtomes, Other Microtomes, and Microtome Accessories. The microtome instruments segment is expected to dominate the microtome market. High expenditure on microtome instruments and their essential use in the histological diagnosis of various diseases are the key factors driving the growth of the automated microtome market.
Asia Pacific is estimated to register the highest CAGR during the forecast period
In this report, the microtome market is segmented into four major regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period.
The growth in this market is primarily driven by the rising disposable income of the middle-class population, infrastructural developments, and the rising penetration of diagnostic technologies in Asian countries such as India and China in addition, the rising incidence of cancer and the growing focus of global medical device companies on expanding their presence in emerging Asia Pacific countries are some of the key factors.
Market Dynamics
Drivers
- Rising Prevalence of Cancer
- Growing Demand for Digital Pathology
- Recommendations for Cancer Screening
- Availability of Reimbursement
Challenges
- Lack of Skilled Professionals
- Availability of Refurbished Products
Opportunities
- Growing Focus on Personalized Medicine
- Emerging Economies
Companies Mentioned
- AGD BIOMEDICALS Pvt. Ltd. (India)
- Amos scientific Pty. Ltd. (Australia)
- Boeckeler Instruments, Inc. (US)
- Bright Instruments (UK)
- Campden Instruments (UK)
- Cardinal Health (US)
- Danaher Corporation (US)
- Diapath S.p.A. (Italy)
- Histo-Line Laboratories (Italy)
- Jinhua Yidi Medical Equipment Co. Ltd. (China)
- LABOID INTERNATIONAL (India)
- Lafayette Instrument Company (US)
- Lupetec (Brazil)
- Medimeas (India)
- MEDITE Medical GmbH (Germany)
- microTec Laborgerate GmbH (Germany)
- MILESTONE MEDICAL (US)
- PHC holdings corporation (Japan)
- RWD Life Science Co. Ltd. (China)
- Sakura Finetek USA, Inc. (US)
- Shenzhen Dakewei Biotechnology Co. Ltd. (China)
- SLEE medical GmbH (Germany)
- SM Scientific Instruments Pvt. Ltd. (India)
- Ted Pella, Inc. (US)
For more information about this report visit https://www.researchandmarkets.com/r/in6nrm
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
